AWH Capital’s Enzo Biochem, Inc. ENZ Stock Holding History

AWH Capital’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-15,000	Closed	-$38K	–	37
2020 Q1	$38K	Buy	+15,000	New	+$36.8K	0.21%	18

Other funds holding ENZ

HFA

Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

EGA

Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

RAM

Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return

AWH Capital's ENZ Position: Q2 2020 in Review

AWH Capital sold out of Enzo Biochem, Inc. (ENZ) in Q2 2020, closing a stake of 15,000 shares — an estimated $38K sold.

AWH Capital first reported a position in ENZ in Q1 2020 and held it in 1 quarter. The position peaked at $38K in Q1 2020. 84 funds tracked by Wall St. Rank hold ENZ as of Q2 2020.

AWH Capital reported no remaining Enzo Biochem, Inc. position as of Q2 2020 after selling out during the quarter.
AWH Capital sold 15,000 Enzo Biochem, Inc. shares in Q2 2020, an estimated $38K.
AWH Capital first reported a position in Enzo Biochem, Inc. in Q1 2020 and held it in 1 quarter.
AWH Capital's Enzo Biochem, Inc. position peaked at $38K in Q1 2020.
84 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q2 2020.

Based on AWH Capital's 13F filing for Q2 2020, filed 14 Aug 2020.